These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20102407)

  • 41. HER2-amplified endometrial carcinoma and AFP-producing endometrial carcinoma.
    Otani T; Matsumura N; Ito A
    Mod Pathol; 2022 Dec; 35(12):2027-2028. PubMed ID: 36065013
    [No Abstract]   [Full Text] [Related]  

  • 42. Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma.
    Hagemann IS; Bridge JA; Tafe LJ; Hameed MR; Moncur JT; Bellizzi AM; Dolan M; Vasalos P; Kane ME; Souers RJ; Yemelyanova A
    Arch Pathol Lab Med; 2023 Oct; 147(10):1148-1157. PubMed ID: 36538387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of ERBB2 amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assays.
    Robinson CL; Harrison BT; Ligon AH; Dong F; Maffeis V; Matulonis U; Nucci MR; Kolin DL
    Mod Pathol; 2021 Mar; 34(3):603-612. PubMed ID: 33077919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer.
    Wang C; Tran DA; Fu MZ; Chen W; Fu SW; Li X
    J Cancer; 2020; 11(7):1693-1701. PubMed ID: 32194781
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and HER-2/neu receptors in Endometrial Carcinoma and their associations with histological types, grades and stages of the tumor.
    Waqar S; Khan SA; Sarfraz T; Waqar S
    Pak J Med Sci; 2018; 34(2):266-271. PubMed ID: 29805391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The significance of markers in the diagnosis of endometrial cancer.
    Żyła MM; Wilczyński JR; Kostrzewa M; Księżakowska-Łakoma K; Nowak M; Stachowiak G; Szyłło K; Stetkiewicz T
    Prz Menopauzalny; 2016 Nov; 15(3):176-185. PubMed ID: 27980530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis.
    Zhang Y; Zhao D; Gong C; Zhang F; He J; Zhang W; Zhao Y; Sun J
    World J Surg Oncol; 2015 Jun; 13():208. PubMed ID: 26108802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of the HER-2/neu oncogene in gynecologic cancers.
    Cirisano FD; Karlan BY
    J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy.
    Ross JS; Fletcher JA
    Semin Cancer Biol; 1999 Apr; 9(2):125-38. PubMed ID: 10202134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
    Saffari B; Jones LA; el-Naggar A; Felix JC; George J; Press MF
    Cancer Res; 1995 Dec; 55(23):5693-8. PubMed ID: 7585656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
    Riben MW; Malfetano JH; Nazeer T; Muraca PJ; Ambros RA; Ross JS
    Mod Pathol; 1997 Aug; 10(8):823-31. PubMed ID: 9267826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluorescence in situ hybridization analysis of HER-2/neu, c-myc, and p53 in endometrial cancer.
    Williams JA; Wang ZR; Parrish RS; Hazlett LJ; Smith ST; Young SR
    Exp Mol Pathol; 1999 Dec; 67(3):135-43. PubMed ID: 10600396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
    Rasty G; Murray R; Lu L; Kubilis P; Benrubi G; Masood S
    Ann Clin Lab Sci; 1998; 28(3):138-43. PubMed ID: 9646853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
    Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study.
    Xu M; Schwartz P; Rutherford T; Azodi M; Santin A; Silasi D; Martel M; Hui P
    Histopathology; 2010 Jan; 56(2):269-73. PubMed ID: 20102407
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.